Doug Brunk is a San Diego-based award-winning reporter who began covering health care in 1991. Before joining the company, he wrote for the health sciences division of Columbia University and was an associate editor at Contemporary Long Term Care magazine when it won a Jesse H. Neal Award. His work has been syndicated by the Los Angeles Times and he is the author of two books related to the University of Kentucky Wildcats men's basketball program. Doug has a master’s degree in magazine journalism from the S.I. Newhouse School of Public Communications at Syracuse University. Follow him on Twitter @dougbrunk.
News
Questions about optimal dosing of isotretinoin persist, expert says
“It seems that the general agreement is to treat until clearance and then treat for another 2 months,” Dr. Diane M. Thiboutot said.
News
Lipedema: A potentially devastating, often unrecognized disease
“If patients with lipedema gain weight, the problem becomes even worse,” Dr. C. William Hanke said.
News
Gowning up: Is it necessary when examining patients with atopic dermatitis?
“Make a concerted effort to look not just at lesion severity but to assess body surface area,” Dr. Jonathan I. Silverberg advised.
News
New AAD guidelines eye comorbidities in adults with atopic dermatitis
The guidelines are the first in a four-part series on AD expected to be published over the next 1-2 years.
News
Perception of atopic dermatitis severity often differs between patients, physicians
“The use of multiple assessment tools that measure different domains could potentially help better capture the broad manifestations of AD.”
News
Pruritus in elderly patients: Not a diagnosis
“That’s just a symptom with a million etiologies,” Dr. Eric L. Simpson said.
News
More frequent secukinumab dosing found to benefit overweight psoriasis patients
“The need for individualized treatment in psoriasis is very real,” Dr. Raj Chovatiya said.
News
Phase 2 studies of novel JAK1 inhibitor for HS show promise
Specifically targeting JAK1 may reduce cytokine signaling involved in HS pathogenesis while limiting JAK2-mediated cytopenias.
News
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”
News
Hand eczema and atopic dermatitis closely linked
“As clinicians, we sometimes need to rule out a few differentials, including psoriasis and T-cell lymphoma,” Dr. Jacob P. Thyssen said.
News
Sorting out sleep complaints in children with AD can be complex
“There’s a loss of about 50 minutes of sleep per night in children with AD,” Dr. Stephen H. Sheldon said.
News
Key questions to ask atopic dermatitis patients with sleep complaints
Assessment tools to consider are the Epworth Sleepiness Scale, the Insomnia Severity Index, and the STOP-Bang questionnaire.
News
Longitudinal course of atopic dermatitis often overlooked, expert says
“Understanding the long-term course may improve our ability to phenotype, prognosticate, and personalize our care,” Dr. Raj Chovatiya said.
News
Itch-dominant atopic dermatitis often flies under the radar
A disconnect often exists between clinician-reported and patient-reported outcome measures, says Dr. Jonathan Silverberg.
News
Atopic dermatitis can be especially burdensome in the elderly
There is good data on higher relative risk of osteoporosis/fractures and dementia specifically among older adults with AD.